Compare Adaptive Biotechnologies Corp (ADPT) vs VNET Group Inc (VNET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs VNET Group Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while VNET Group Inc trades at $7.54 (market cap $2.14B). The key difference: Adaptive Biotechnologies Corp is the larger of the two by market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, VNET Group Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | VNET | |
|---|---|---|
Market Cap | $4.04B | $2.14B |
Sector | Health | Technology |
52-Week High | $25.45 | $14.03 |
52-Week Low | $12.30 | $6.29 |
Enterprise Value | $4.10B | $5.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →
